Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

721
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
721
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

287
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
287
Dementia01:30

Dementia

208
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
208

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metagenomic Sequencing Analysis for Acne Using Machine Learning Methods Adapted to Single or Multiple Data.

Computational and mathematical methods in medicine·2021
Same journal

Correction to "Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism".

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Empirical Analysis of the Nursing Effect of Intelligent Medical Internet of Things in Postoperative Osteoarthritis.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Evaluation and Analysis of the Intervention Effect of Systematic Parent Training Based on Computational Intelligence on Child Autism.

Computational and mathematical methods in medicine·2024
Same journal

RETRACTION: Humanistic Spirit Training of Medical Students Based on Multisource Medical Data Fusion.

Computational and mathematical methods in medicine·2024
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

393

Alzheimer's Disease Classification Based on Image Transformation and Features Fusion.

Hongfei Jia1, Yu Wang1, Yifan Duan1

  • 1Beijing Key Laboratory of Big Data Technology for Food Safety, School of Artificial Intelligence, Beijing Technology and Business University, Beijing 100048, China.

Computational and Mathematical Methods in Medicine
|January 7, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new computer-based method to help doctors identify different stages of Alzheimer's disease. By using brain scans and advanced mathematical techniques, the researchers created a system that accurately distinguishes between healthy individuals and those with memory issues or cognitive decline.

Keywords:
Deep LearningFunctional MRIFeature FusionDiagnostic Imaging

Frequently Asked Questions

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Related Experiment Videos

Last Updated: Oct 7, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

393
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Area of Science:

  • Neuroimaging and Alzheimer's disease classification within medical informatics
  • Computational neuroscience and diagnostic imaging technologies

Background:

No prior work had resolved the optimal integration of diverse brain scan transformations for automated diagnostic systems. It was already known that medical experts increasingly rely on computational tools to interpret complex neuroimaging data. This gap motivated researchers to explore how artificial intelligence might enhance the detection of cognitive decline. Prior research has shown that functional magnetic resonance imaging provides valuable insights into brain activity patterns. That uncertainty drove the development of specialized models capable of processing these intricate datasets. Existing diagnostic frameworks often struggle to synthesize multiple imaging features into a single, cohesive classification output. Scientists have long sought more reliable ways to differentiate between subtle stages of neurological impairment. This study addresses the need for robust analytical pipelines that leverage deep learning to improve clinical decision-making processes.

Purpose Of The Study:

The aim of this study is to develop a classification method for Alzheimer's disease using functional magnetic resonance imaging. Researchers sought to address the challenge of accurately staging cognitive decline through advanced computational techniques. The motivation stems from the need for more precise diagnostic tools to support medical personnel in clinical environments. By combining deep learning with specific image transformations, the team intended to improve existing detection capabilities. This work explores how integrating multiple feature sets can enhance the performance of automated diagnostic systems. The authors specifically focused on creating a pipeline that synthesizes regional homogeneity and low-frequency amplitude data. They aimed to demonstrate that this fusion process leads to more reliable patient categorization. This research provides a structured approach to solving the complexities inherent in neuroimaging-based disease classification.

Main Methods:

The review approach focuses on a novel classification pipeline designed for functional magnetic resonance imaging data. Investigators initiated the process by applying specific preprocessing steps to raw brain scans. They subsequently generated two distinct image representations to capture functional brain activity. The team utilized an enhanced version of a deep learning architecture to extract relevant information from these representations. A mathematical fusion technique then combined the resulting feature sets into a unified input for the classifier. A support vector machine served as the final engine to determine the diagnostic category of each subject. The researchers validated their approach by testing it across multiple cohorts representing different levels of cognitive health. This systematic workflow ensures that diverse data types contribute equally to the final diagnostic output.

Main Results:

The proposed approach achieved a 95.00% accuracy rate when differentiating between significant memory concern and mild cognitive impairment. Key findings from the literature indicate that the system also reached 92.00% accuracy for normal control versus Alzheimer's disease. Furthermore, the model demonstrated 91.30% accuracy when comparing normal control subjects to those with significant memory concern. These performance metrics suggest that the combined feature fusion strategy is highly effective for diagnostic tasks. The experimental data confirm that the integration of multiple image transformations improves overall classification reliability. The authors report that their methodology remains robust across all tested patient categories. These high success rates validate the utility of the improved deep learning model in clinical settings. The results provide strong evidence for the feasibility of this automated diagnostic framework.

Conclusions:

The authors propose that their integrated framework offers a reliable pathway for staging neurodegenerative conditions. This synthesis suggests that combining distinct image transformations enhances the sensitivity of diagnostic models. The results indicate that the fusion of regional homogeneity and low-frequency amplitude features provides a comprehensive view of brain pathology. Researchers claim that their approach outperforms traditional single-feature classification methods by capturing more nuanced data patterns. The evidence supports the utility of support vector machines in finalizing diagnostic categories for patients. These findings imply that automated systems can assist clinicians in managing memory-related disorders more effectively. The study demonstrates that the proposed pipeline maintains high accuracy across various patient groups. Future clinical applications may benefit from the robustness exhibited by this multi-stage computational strategy.

The researchers propose a pipeline utilizing 3DPCANet for feature extraction followed by canonical correlation analysis to merge data. This process feeds into a support vector machine, which performs the final categorization of patients based on their specific cognitive status.

The study employs mean regional homogeneity and mean amplitude of low-frequency amplitude as the two primary image transformations. These specific metrics allow the system to capture distinct functional characteristics from the raw brain scans before the fusion process occurs.

The authors indicate that 3DPCANet is necessary to handle the complex, three-dimensional nature of the brain imaging data. This model allows for the effective extraction of hierarchical features that would otherwise remain inaccessible through simpler, two-dimensional analytical approaches.

Canonical correlation analysis serves as the integration tool for combining the two distinct feature sets. This mathematical technique ensures that the most relevant information from both regional homogeneity and low-frequency amplitude maps is preserved for the final classification step.

The system achieved a 95.00% accuracy rate when distinguishing between significant memory concern and mild cognitive impairment. This performance is compared against the 92.00% accuracy for normal control versus Alzheimer's disease and 91.30% for normal control versus significant memory concern.

The researchers propose that this methodology provides a robust and effective solution for clinical diagnostics. They claim that their technique proves the feasibility of using automated image fusion to identify early signs of neurodegeneration in a reliable manner.